Hib Disease
An invasive bacterial infection caused by Haemophilus influenzae type b that can lead to meningitis, bloodstream infection, pneumonia, or airway obstruction.
What causes Hib Disease?
Hib disease is caused by encapsulated Haemophilus influenzae type b bacteria. It spreads through respiratory droplets and close contact with an infected person or asymptomatic carrier.
Symptoms and what to notice
Symptoms depend on the infected site and may include fever, severe headache, stiff neck, confusion, poor feeding, irritability, breathing difficulty, cough, chest pain, joint pain, or rapidly worsening illness.
How long can it last?
The incubation period is not precisely defined and may be only a few days. Invasive illness can progress rapidly and requires immediate antibiotics. Recovery varies from days to weeks, with longer rehabilitation when neurological injury occurs.
How serious is Hib Disease?
Hib can cause meningitis, sepsis, epiglottitis, pneumonia, cellulitis, septic arthritis, hearing loss, brain injury, and death. Infants, young children, and people with absent spleen function or certain immune conditions are at higher risk.
Treatment and management
Invasive Hib disease requires urgent hospital antibiotics, commonly ceftriaxone or cefotaxime, plus airway, seizure, shock, or intensive-care support as needed. Rifampin preventive treatment may be recommended for certain close contacts.
Vaccine: who and when?
Products: ActHIB, Hiberix, and PedvaxHIB are Hib-only conjugate vaccines; Pentacel and Vaxelis are combination vaccines. Series length depends on the product. Routine doses begin at 2 months with a booster at 12-15 months; Vaxelis is used for primary doses but not the booster.
Cost note: Cost varies by product and provider. Routine Hib vaccination is generally covered by U.S. insurance and is available through the Vaccines for Children program for eligible children.
Trusted source
Patient cost varies by insurance, provider, location, and eligibility. Coverage and public-health access differ, so listed prices are examples rather than guaranteed patient prices. This page is for general education and does not replace individualized medical advice, diagnosis, vaccination assessment, or treatment.
Hib Disease: Symptoms, Causes, Treatment, Prevention, and Vaccine Information
Haemophilus influenzae type b was once a leading cause of bacterial meningitis in young U.S. children. Conjugate vaccines introduced in the late twentieth century produced a dramatic decline in invasive disease. Hib is not influenza and has no connection to seasonal flu despite its historical name. The bacterium may live in the upper airway without symptoms, but when it enters blood or normally sterile tissues it can cause a medical emergency.
Important: This page is for general education. It does not replace diagnosis, treatment, vaccination advice, or emergency care from a qualified healthcare professional.
Quick Facts
| Topic | Current information |
|---|---|
| Cause | Hib disease is caused by encapsulated Haemophilus influenzae type b bacteria. It spreads through respiratory droplets and close contact with an infected person or asymptomatic carrier. |
| Main symptoms | Symptoms depend on the infected site and may include fever, severe headache, stiff neck, confusion, poor feeding, irritability, breathing difficulty, cough, chest pain, joint pain, or rapidly worsening illness. |
| Typical course | The incubation period is not precisely defined and may be only a few days. Invasive illness can progress rapidly and requires immediate antibiotics. Recovery varies from days to weeks, with longer rehabilitation when neurological injury occurs. |
| Treatment | Invasive Hib disease requires urgent hospital antibiotics, commonly ceftriaxone or cefotaxime, plus airway, seizure, shock, or intensive-care support as needed. Rifampin preventive treatment may be recommended for certain close contacts. |
| Vaccine status | Products: ActHIB, Hiberix, and PedvaxHIB are Hib-only conjugate vaccines; Pentacel and Vaxelis are combination vaccines. Series length depends on the product. Routine doses begin at 2 months with a booster at 12-15 months; Vaxelis is used for primary doses but not the booster. |
History and Public-Health Importance
The organism was mistakenly suspected as a cause of influenza during the 1890 pandemic, explaining its name. Later research showed that influenza is viral and that encapsulated H. influenzae type b caused meningitis and other invasive bacterial disease. Early polysaccharide vaccines did not protect infants well. Protein-conjugate vaccines solved that problem and created population-level protection by reducing carriage and transmission.
What Causes Hib Disease?
Hib disease is caused by encapsulated Haemophilus influenzae type b bacteria. It spreads through respiratory droplets and close contact with an infected person or asymptomatic carrier.
Hib spreads through respiratory droplets and secretions during close or prolonged contact. Healthy carriers can transmit it without appearing ill. Exposure does not always cause disease; risk depends on age, immunity, vaccination, and underlying conditions. Hib is distinct from non-typeable H. influenzae and other capsule types, so the Hib vaccine does not prevent every H. influenzae infection.
Symptoms and Typical Course
Symptoms depend on the infected site and may include fever, severe headache, stiff neck, confusion, poor feeding, irritability, breathing difficulty, cough, chest pain, joint pain, or rapidly worsening illness.
Meningitis may cause fever, headache, stiff neck, vomiting, altered alertness, or bulging fontanelle in infants. Epiglottitis can cause drooling, muffled voice, stridor, and sudden airway obstruction. Bloodstream infection may present with fever, lethargy, low blood pressure, or shock. Rapid progression means suspected invasive disease should not be watched at home.
Complications and Who Is at Higher Risk
Hib can cause meningitis, sepsis, epiglottitis, pneumonia, cellulitis, septic arthritis, hearing loss, brain injury, and death. Infants, young children, and people with absent spleen function or certain immune conditions are at higher risk.
Survivors of Hib meningitis can have hearing loss, seizures, learning difficulties, or other neurological disability. Epiglottitis can block the airway. Sepsis can produce shock and multi-organ failure. Risk is increased in children younger than five, people without a functioning spleen, stem-cell transplant recipients, and selected people with immunodeficiency.
How It Is Diagnosed
Blood, cerebrospinal fluid, joint fluid, or another sterile-site specimen is cultured and may undergo molecular testing. Species and serotype identification are important for surveillance and contact management. When meningitis or epiglottitis is suspected, treatment and airway protection should not be delayed for final laboratory confirmation.
Treatment and Recovery
Invasive Hib disease requires urgent hospital antibiotics, commonly ceftriaxone or cefotaxime, plus airway, seizure, shock, or intensive-care support as needed. Rifampin preventive treatment may be recommended for certain close contacts.
A third-generation cephalosporin such as ceftriaxone or cefotaxime is commonly started while susceptibility testing is pending. Therapy is tailored to infection site and laboratory results. Meningitis needs hospital monitoring and supportive care; epiglottitis requires expert airway management. Certain household or childcare contacts receive rifampin to eliminate carriage and prevent secondary cases.
Vaccine Information
Products: ActHIB, Hiberix, and PedvaxHIB are Hib-only conjugate vaccines; Pentacel and Vaxelis are combination vaccines. Series length depends on the product. Routine doses begin at 2 months with a booster at 12-15 months; Vaxelis is used for primary doses but not the booster.
ActHIB and Hiberix use a tetanus-toxoid carrier, while PedvaxHIB uses a meningococcal outer-membrane protein carrier. ActHIB, Hiberix, Pentacel, or Vaxelis generally require primary doses at 2, 4, and 6 months; PedvaxHIB uses primary doses at 2 and 4 months. Every series includes a booster at 12 through 15 months, using ActHIB, Hiberix, Pentacel, or PedvaxHIB rather than Vaxelis. Special schedules apply after splenectomy or stem-cell transplant.
Prevention
Complete the product-appropriate vaccine series, use hand and respiratory hygiene, and follow public-health advice after an invasive case. Vaccination protects against type b but not all H. influenzae strains, so serious compatible symptoms still need evaluation. Close contacts should not take leftover antibiotics; prophylaxis decisions depend on household composition and vaccination status.
When to Seek Medical Care
Call emergency services for breathing difficulty, drooling with inability to swallow, blue color, severe lethargy, stiff neck, seizures, or signs of shock. Infants with fever, poor feeding, irritability, or abnormal alertness need prompt assessment.
Frequently Asked Questions
Is Hib the same as influenza?
No. Hib is a bacterium; influenza is caused by flu viruses. The similar name is historical.
Does Hib vaccine prevent every H. influenzae infection?
No. It targets type b. Other capsule types and non-typeable strains can still cause disease.
Why do product schedules differ?
The vaccines use different carrier proteins and formulations, producing different numbers of primary doses before the common booster.
Do adults need Hib vaccine?
Most adults do not. It is recommended in selected high-risk situations, such as certain people without a spleen or after stem-cell transplant.
Key Takeaway
Hib vaccination transformed a once-common childhood emergency into a rare disease. Completing the correct product schedule and responding rapidly to invasive symptoms remain essential.
Medical, treatment, and vaccine information was reviewed against official U.S. public-health guidance available through September 2026.